Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
Benzinga · 1d ago
Peering Into Abiomed's Recent Short Interest
Benzinga · 11/17 15:12
Will Investors Notice Exciting Sign On Abiomed's Chart?
Benzinga · 11/16 14:49
M&A investors have tough, unexpected week with Rogers deal termination, Albertsons dividend
Seekingalpha · 11/06 14:00
Here's How Much $100 Invested In Abiomed 20 Years Ago Would Be Worth Today
Benzinga · 11/04 15:39
5 Analysts Have This to Say About Abiomed
Benzinga · 11/02 18:08
Morgan Stanley Upgrades Abiomed to Equal-Weight, Raises Price Target to $380
Benzinga · 11/02 11:30
Deutsche Bank Downgrades Abiomed to Hold, Raises Price Target to $388
Benzinga · 11/02 10:12
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Benzinga · 11/02 09:07
--Morgan Stanley Upgrades Abiomed to Equalweight From Underweight, Boosts Price Target to $380 From $235
--Morgan Stanley Upgrades Abiomed to Equalweight From Underweight, Boosts Price Target to $380 From $235
MT Newswires · 11/02 08:22
--Deutsche Bank Downgrades Abiomed to Hold From Buy, Adjusts Price Target to $388 From $355
--Deutsche Bank Downgrades Abiomed to Hold From Buy, Adjusts Price Target to $388 From $355
MT Newswires · 11/02 08:00
Gartner, Sony, Uber And Other Big Gainers From Tuesday
Benzinga · 11/02 06:57
Hot Stocks: VRNS, ZBRA plunge on earnings; IDXX climbs; ABMD surges 50% on JNJ merger deal
Seekingalpha · 11/01 22:03
What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
Benzinga · 11/01 20:28
Poseidon’s $10.9 billion take-private deal for Atlas Corp. sets sail at sweetened price · 11/01 19:25
Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
Benzinga · 11/01 18:57
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 11/01 18:10
Abiomed unlikely to see higher bid given size of J&J premium - analyst
Seekingalpha · 11/01 17:51
MNSO and CLEU among mid-day movers
Seekingalpha · 11/01 17:40
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 11/01 16:38
Webull provides a variety of real-time ABMD stock news. You can receive the latest news about Abiomed Inc through multiple platforms. This information may help you make smarter investment decisions.
About ABMD
ABIOMED, Inc. is a medical technology provider, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The Company's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.